The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAAA.L Regulatory News (AAA)

  • There is currently no data for AAA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension of reporting deadline & portfolio update

26 Jun 2020 13:22

RNS Number : 2584R
All Active Asset Capital Limited
26 June 2020
 

26 June 2020

 

All Active Asset Capital Limited

('AAAC' or 'the Company')

Extension of reporting deadline for publication of the annual report and financial statements for the year ended 31 December 2019 ('Annual Report')

Portfolio update

Change of broker

Extension of financial reporting deadline and update on investment in Myanmar Allure Group Co., Ltd

AAAC has a 7% equity investment in Myanmar Allure Group Co., Ltd. ("the Myanmar Investment"), a company that owns and operates a combined hotel, resort and gaming facility in Myanmar. The COVID-19 lockdown has prevented the Company from obtaining up to date information about the trading performance and financial situation of the Myanmar Investment, which was the sole investment held by AAAC as at 31 December 2019. The Company has been informed that the facility has been closed, due to the COVID-19 situation.

 

The Myanmar Investment (reflected in the Company's balance sheet as at 31 December 2018 at a valuation of £971,252) is a substantial component of the Company's gross assets in the Company's Annual Report and, as an investment in an unlisted equity security, the Myanmar Investment requires an annual assessment of its fair value ("the Valuation Report") as part of the Company's audit process.

 

Due to the COVID-19 pandemic and lockdown measures in Myanmar, preparation of the Valuation Report has been delayed. Given the material nature of the Myanmar Investment, the Valuation Report is fundamental to an audit opinion within the Annual Report.

 

The Company has applied to AIM Regulation, pursuant to the guidance provided by AIM Regulation in "Inside AIM" on 26 March 2020, for an additional period of up to three months to publish the Annual Report. AIM Regulation has granted the extension and therefore the Company will publish the Annual Report by no later than 30 September 2020. If it is possible to publish the Annual Report before this date, then the Board will seek to do so as promptly as possible.

 

The Company has consulted with its British Virgin Islands ("BVI") lawyers and has been advised that it is not necessary for the Company to file audited financial statements with the Registry of Corporate Affairs in the BVI. Accordingly, a delay in the publication of the Annual Report will not breach any regulations in the BVI.

Portfolio update

The Company did not make any new investments during the year ended 31 December 2019. In 2020, the Company made several investments relating to Asimilar Group plc ("Asimilar").

The Company's current investment portfolio comprises three assets: (i) the Myanmar Investment, as described above; (ii) equity, warrants and options over warrants in Asimilar; and (iii) cash reserves amounting to approximately £1.1 million following completion of the recent placing.

Asimilar is an AIM quoted technology-focused investing company. In the first half of 2020 the Company has acquired and holds the following interests in Asimilar:

- 1,200,000 Asimilar shares (representing 1.14% of Asimilar's current issued share capital), the details of which were announced by AAAC on 30 March 2020.

 

- an option to acquire warrants over 15,500,000 Asimilar shares, exercisable at 6p per Asimilar share each, expiring on 31 October 2020, the details of which were announced by AAAC on 14 May 2020.

 

- an option to acquire warrants over 5,000,000 Asimilar shares, exercisable at 18p per Asimilar share each, expiring on 30 September 2020, the details of which were announced by AAAC on 14 May 2020.

 

- an option to acquire warrants over 1,200,000 Asimilar shares, exercisable at 5p per Asimilar share each, expiring on 31 May 2022, the details of which were announced by AAAC on 20 March 2020.

 

- warrants over 240,000 Asimilar shares, exercisable at 5p per Asimilar share each, expiring on 31 May 2022, the details of which were announced by AAAC on 20 March 2020.

 

These investments in equity, warrants and options over warrants in Asimilar have an unaudited current carrying value of approximately £1.1 million, being their acquisition price.

Asimilar's shares were suspended from trading on AIM on 14 February 2020, due to Asimilar seeking to make a potential investment in Sentiance NV ("Sentiance"), which would comprise a 9.3% new equity stake, with options, which would increase Asimilar's holding to up to 35.9% of Sentiance's enlarged issued share capital. Sentiance is a private Belgian company, developing artificial intelligence software, machine learning and contextual behavioural data science.

Asimilar's potential Sentiance investment was classified as a reverse takeover under the AIM Rules; Asimilar's shares were trading at 47.5 pence when suspended. On 12 March 2020, Asimilar announced a placing to raise £7.5m at 60 pence per share, conditional on a number of matters, including Asimilar's enlarged share capital being admitted to trading on AIM. There can be no guarantee that Asimilar's potential Sentiance investment, nor the Asimilar placing will be completed, or of the final terms and timing of these transactions.

Change of Broker 

Allenby Capital Limited is now the Company's sole broker and remains the Company's nominated adviser.

 

For further information:

 

All Active Asset Capital Limited

James Normand, Non-Executive Chairman

Rodger Sargent, Executive Director

T: +44 (0) 7779 799431

www.aaacap.com

 

Allenby Capital Limited (Nominated Adviser and Broker)

Nick Athanas / Alex Brearley

T: +44 (0) 203 328 5656

www.allenbycapital.com

 

Buchanan (Financial PR)

Richard Oldworth / Chris Lane / Toto Berger

T: +44 (0) 207 466 5000

E: AAAC@buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFFMTTMTTTBMM
Date   Source Headline
18th Feb 20212:01 pmRNSHolding(s) in Company
17th Feb 20214:41 pmRNSHolding(s) in Company
17th Feb 20214:41 pmRNSSecond Price Monitoring Extn
17th Feb 20214:36 pmRNSPrice Monitoring Extension
17th Feb 20211:54 pmRNSGrant of 200m AAA options exercisable at 50p
15th Feb 202111:51 amRNSSale of investment
15th Feb 20217:00 amRNSAgreement by MESH and AAQUA to acquire Sentiance
5th Feb 202110:10 amRNSProposed Non-Executive Director appointment
4th Jan 20217:00 amRNSBlock admission six monthly return
31st Dec 202011:30 amRNSMESH Holdings increases stake in Sentiance
22nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20204:35 pmRNSPrice Monitoring Extension
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:35 pmRNSPrice Monitoring Extension
18th Dec 20202:05 pmRNSSecond Price Monitoring Extn
18th Dec 20202:00 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSOption agreement with AAQUA B.V.
17th Dec 20207:00 amRNSAdditional Convertible Loan to MESH Holdings plc
15th Dec 20203:32 pmRNSUnaudited financial statements -period to 11.12.20
10th Dec 20206:24 pmRNSHolding(s) in Company
9th Dec 202010:10 amRNSNOTIFICATION OF MAJOR HOLDINGS
4th Dec 20205:50 pmRNSHolding(s) in Company
4th Dec 202010:28 amRNSAdmission of Placing Shares
3rd Dec 20207:00 amRNSFurther update on Placing
2nd Dec 20207:00 amRNSUpdate on Placing
1st Dec 20207:00 amRNSTotal Voting Rights
30th Nov 20207:00 amRNSConvertible loan and issue of warrants
24th Nov 20207:00 amRNSHolding(s) in Company
20th Nov 20208:10 amRNSAdmission of Placing Shares
19th Nov 20203:03 pmRNSHolding(s) in Company
19th Nov 20207:00 amRNSRevision to Placing
11th Nov 202011:01 amRNSHolding(s) in Company
10th Nov 20201:18 pmRNSUpdate on Placing
2nd Nov 20207:00 amRNSTotal Voting Rights
26th Oct 202012:32 pmRNSResult of Annual General Meeting
23rd Oct 20207:00 amRNSPlacing to raise £11.5 million
5th Oct 202010:54 amRNSNotice of Annual General Meeting
30th Sep 20207:00 amRNSInterim Results
28th Sep 20201:42 pmRNSResults for the year ended 31 December 2019
1st Sep 20209:31 amRNSStatement re Announcement by Asimilar
1st Sep 20207:00 amRNSTotal Voting Rights
25th Aug 20207:57 amRNSStatement re Announcement by Asimilar
20th Aug 202012:10 pmRNSStatement re Announcement by Asimilar
19th Aug 202012:53 pmRNSTransfer of warrants and PCA dealing
14th Aug 20204:00 pmRNSNotification of Major Holdings
14th Aug 20207:00 amRNSAmendment to terms of Warrants
7th Aug 202011:43 amRNSChange in Asimilar Options Consideration
3rd Aug 20203:41 pmRNSStatement re Announcement by Asimilar
3rd Aug 20207:00 amRNSTotal Voting Rights
31st Jul 20202:13 pmRNSStatement re Announcement by Asimilar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.